AccessMyLibrary provides FREE access to over 30 million articles from top publications available through your library.

The Brown University Geriatric Psychopharmacology Update articles from April 2007

874 total articles

Set up an RSS feed
Close Set up an RSS feed that alerts you when new articles from The Brown University Geriatric Psychopharmacology Update are available.
XML Add to My Yahoo! Add to My AOL Add to Google Subscribe in NewsGator
Frequently asked questions about RSS feeds
to find out when new articles for The Brown University Geriatric Psychopharmacology Update arrive.

The Brown University Geriatric Psychopharmacology Update archives from April 2007

Parkinson's disease drugs implicated in cardiac-valve regurgitation.(Heart Disease)(Clinical report)
April 1, 2007... precis * Results from 2 European studies show that pergolide and cabergoline, both ergot-derived dopamine agonists used in treating Parkinson's disease (PD), are associated with the development of valvular heart disease; significantly...

Daily SSRI use increases fracture risk in older population.(SSRIs and Fractures)(selective serotonin reuptake inhibitor)(Clinical report)
April 1, 2007... precis * A prospective cohort study of 5,008 community-dwelling adults aged 50 and older were followed over five years for incident fractures. Daily SSRI (selective serotonin reuptake inhibitor) use was reported by 137 subjects *...

Neuroleptic malignant syndrome and risperidone.(Adverse Events)(Clinical report)
April 1, 2007... Neuroleptic malignant syndrome (NMS) is a rare but serious and potentially fatal adverse effect caused by dopamine receptor blockade associated with the use of antipsychotic agents. The incidence of NMS has been estimated to be up to 2.4%, and...

Once-daily versus twice-daily effects of memantine in AD patients.(What's New in Research)(Clinical report)
April 1, 2007... precis * The effects of once-daily dosing of memantine 20 mg appear to be similar to the recommended twice-daily dosing in terms of safety and tolerability; once-daily dosing would benefit patient and caregiver through ease of use and...

Citalopram and venlafaxine associated with syndrome of inappropriate secretion of diuretic hormone (SIADH).(Case Report)(Clinical report)
April 1, 2007... Patient: Male, 87 y/o Medications: Citalopram (Celexa), losartan (Hyzaar, Cozaar), omeprazole (Prilosec), allopurinol (Lopurin, Zyloprim), clopidrogel (Plavix), carvedilol (Coreg), simvastatin (Zocor), isosorbide mononitrate (Monoket),...

New U.S. data on common neurological disorders.(News Notes)(Brief article)
April 1, 2007... An update of the most common neurological disorders in the United States indicates that 67 out of 1,000 elderly Americans suffer from Alzheimer's disease (AD). Annual incidence was estimated at 1,275 per 100,000 cases, with 80 years of age or...

New approvals.(From the FDA)(dexmethylphenidate)(Brief article)
April 1, 2007... Final approval has been granted (January 29, 2007) for first-time generic dexmethylphenidate, manufactured by Teva Pharma, to treat attention-deficit/hyperactivity disorder in children and adults. The Reference Listed Drug is Focalin Tablets....

Rasagiline (generic): Azilect (brand).(YOUR MEDICATION INFORMATION)(Drug overview)
April 1, 2007... CLASSIFICATION: Irreversible monamine oxidase (MAO) inhibitor COMMON USAGE: Rasagiline is indicated for treatment of the signs and symptoms of Parkinson's disease (PD), and may be taken alone as initial therapy, and later on in combination...

©2009 Gale, a part of Cengage Learning. All rights reserved.
About us | FAQs | Contact us | Privacy policy | Terms and conditions
Other Gale sites: Encyclopedia.com | HighBeam Research | Acquire Content | Books & Authors | Goliath | MovieRetriever | Smart QandA